Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Little

Showing results (81-90 of 130) with videos related to

Pageof 13
Sort By:
Kidney International|August 31, 2018
Alkylating histone deacetylase inhibitors may have therapeutic value in experimental myeloperoxidase-ANCA vasculitisDearbhaile Dooley, Mirjan M van Timmeren, Vincent P O'Reilly, et al.
Journal of the American Society of Nephrology : JASN|September 14, 2021
The Clinical Application of Urine Soluble CD163 in ANCA-Associated VasculitisSarah M Moran, Jennifer Scott, Michael R Clarkson, et al.
Viruses|August 10, 2021
Dynamic Assay for Profiling Anti-SARS-CoV-2 Antibodies and Their ACE2/Spike RBD Neutralization CapacityThomas Phelan, Jean Dunne, Niall Conlon, et al.
Scientific Reports|December 2, 2016
Changes in urinary metabolomic profile during relapsing renal vasculitisBahjat Al-Ani, Martin Fitzpatrick, Hamad Al-Nuaimi, et al.
Kidney Medicine|January 23, 2023
Plasma Exchange for ANCA-Associated Vasculitis: An International Survey of Patient PreferencesDavid Collister, Mark Farrar, Lesha Farrar, et al.
Scientific Reports|April 16, 2021
Investigation of type I interferon responses in ANCA-associated vasculitisIsabella Batten, Mark W Robinson, Arthur White, et al.
The Lancet. Rheumatology|May 23, 2024
Identifying key health system components associated with improved outcomes to inform the re-configuration of services for adults with rare autoimmune rheumatic diseases: a mixed-methods studyRosemary J Hollick, Warren R G James, Avril Nicoll, et al.
Annals of the Rheumatic Diseases|January 29, 2013
The characterisation and determinants of quality of life in ANCA associated vasculitisNeil Basu, Andrew McClean, Lorraine Harper, et al.
Kidney International|December 21, 2024
The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trialBalazs Odler, Regina Riedl, Duvuru Geetha, et al.
Rheumatology (Oxford, England)|June 7, 2013
Explaining fatigue in ANCA-associated vasculitisNeil Basu, Andrew McClean, Lorraine Harper, et al.
Pageof 13

Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
Kidney International|August 31, 2018
Alkylating histone deacetylase inhibitors may have therapeutic value in experimental myeloperoxidase-ANCA vasculitisDearbhaile Dooley, Mirjan M van Timmeren, Vincent P O'Reilly, et al.
Journal of the American Society of Nephrology : JASN|September 14, 2021
The Clinical Application of Urine Soluble CD163 in ANCA-Associated VasculitisSarah M Moran, Jennifer Scott, Michael R Clarkson, et al.
Viruses|August 10, 2021
Dynamic Assay for Profiling Anti-SARS-CoV-2 Antibodies and Their ACE2/Spike RBD Neutralization CapacityThomas Phelan, Jean Dunne, Niall Conlon, et al.
Scientific Reports|December 2, 2016
Changes in urinary metabolomic profile during relapsing renal vasculitisBahjat Al-Ani, Martin Fitzpatrick, Hamad Al-Nuaimi, et al.
Kidney Medicine|January 23, 2023
Plasma Exchange for ANCA-Associated Vasculitis: An International Survey of Patient PreferencesDavid Collister, Mark Farrar, Lesha Farrar, et al.
Scientific Reports|April 16, 2021
Investigation of type I interferon responses in ANCA-associated vasculitisIsabella Batten, Mark W Robinson, Arthur White, et al.
The Lancet. Rheumatology|May 23, 2024
Identifying key health system components associated with improved outcomes to inform the re-configuration of services for adults with rare autoimmune rheumatic diseases: a mixed-methods studyRosemary J Hollick, Warren R G James, Avril Nicoll, et al.
Annals of the Rheumatic Diseases|January 29, 2013
The characterisation and determinants of quality of life in ANCA associated vasculitisNeil Basu, Andrew McClean, Lorraine Harper, et al.
Kidney International|December 21, 2024
The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trialBalazs Odler, Regina Riedl, Duvuru Geetha, et al.
Rheumatology (Oxford, England)|June 7, 2013
Explaining fatigue in ANCA-associated vasculitisNeil Basu, Andrew McClean, Lorraine Harper, et al.
Pageof 13